전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved39 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleSung-Soo ParkPreclinical

IMiD treatment (IMiD treatment)

Multiple Myeloma, Relapsed; Multiple Myeloma (MM) · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+5
Trials 39Status Recruiting
CGTLimited DatastaleLiaoning Medical Diagnosis and …Phase 2

Autologous immune Cells (Autologous immune Cells)

Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic) · Lung Cancer (Locally Advanced or Metasta

#LungCancerLocallyAdvancedorMetas#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 31Status Recruiting
CGTLimited DatastalePolina StepenskyPhase 2

HBI0101 CART (HBI0101 CART)

Multiple Myeloma, Refractory to Standard Treatment; Multiple Myeloma, Relapsed · Systemic Sclerosis (SSc)

#SystemicSclerosisSSc#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 4Status Recruiting
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

RNA anti-CD19 CAR T cells (RNA anti-CD19 CAR T cells)

Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 4Status Discontinued
CGTLimited DatastaleTCRCure Biopharma Ltd.Phase 1

Anti ALPP CAR-T cells treatment (Anti ALPP CAR-T cells treatment)

Recurrent or Metastatic Solid Tumors With Positive ALPP · Solid Tumor

#SolidTumor#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Discontinued
AntibodyLimited DatastaleHenan Cancer HospitalPhase 2

durvalumab (Imfinzi, Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer)

SCLC, Extensive Stage · SCLC, Extensive Stage

#SCLCExtensiveStage#Antibody#Phase2#monoclonal-antibody#SCLC+2
Trials 1Status Active
AntibodyLimited DatastaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#monoclonal-antibody#Sanofi
Trials 1Status Recruiting
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

CAR-T Re-treatment (CAR-T Re-treatment)

Multiple Myeloma; Multiple Myeloma in Relapse · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleThe First Affiliated Hospital o…Phase 2

CAR-T treatment (CAR-T treatment)

Multiple Myeloma; Relapsed/Refractory · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#monoclonal-antibody#TreatmentforAdvancedPancreaticCa+1
Trials 1Status Recruiting
AntibodyLimited DatastaleCedars-Sinai Medical CenterPhase 1

Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab (Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#Antibody#Phase1#monoclonal-antibody#GlioblastomaMultiforme+1
Trials 1Status Active
AntibodyLimited DatastaleJanssenPhase 3

daratumumab (Darzalex, Early treatment of relapse with carfilzomib, dexamethasone, daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Janssen
Trials 1Status Recruiting
CGTLimited DatastaleTCRCure Biopharma Ltd.Phase 1

Enhanced ALPP CAR-T treatment (Enhanced ALPP CAR-T treatment)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix)

Primary Central Nervous System Lymphoma · Primary Central Nervous System Lymphoma

#PrimaryCentralNervousSystemLymph#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleHenan Provincial People's Hospi…Preclinical

Gene evolution and molecular response under Bevacizumab treatment (Gene evolution and molecular response under Bevacizumab treatment)

Genetic Change · Genetic Change

#GeneticChange#Antibody#Preclinical#monoclonal-antibody#Henan
Trials 1Status Recruiting
AntibodyLimited DatastaleImmuneering CorporationPhase 2

Treatment Group E (IMM-1-104 + pembrolizumab, IMM-1-104 + pembrolizumab (Treatment Group E))

Advanced Solid Tumor; Pancreatic Adenocarcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#monoclonal-antibody#PancreaticAdenocarcinoma+1
Trials 1Status Recruiting
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 2

Ivonescimab Combined With Chemotherapy (Ivonescimab Combined With Chemotherapy)

Relapsed or Metastatic Thymic Cancer; First-line Treatment · Relapsed or Metastatic Thymic Cancer

#RelapsedorMetastaticThymicCancer#Antibody#Phase2#monoclonal-antibody#First-lineTreatment+1
Trials 1Status Recruiting
AntibodyLimited DatastaleCentre Hospitalier Departementa…Phase 3

Maintenance (Maintenance, Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®, or initiation)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; End Stage Renal Disease · Anti-Neutrophil Cytoplasmic Antibody-Ass

#Anti-NeutrophilCytoplasmicAntibo#Antibody#Phase3#monoclonal-antibody#EndStageRenalDisease+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab (Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab)

Refractory Metastatic Colorectal Cancer · FRα

#FR#Antibody#Phase2#monoclonal-antibody#RefractoryMetastaticColorectalCa+1
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang UniversityPhase 1

NKG2D CAR NK and NKG2D CAR T cells (NKG2D CAR NK and NKG2D CAR T cells)

Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments · Patients With Advanced Solid Tumors With

#PatientsWithAdvancedSolidTumorsW#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting

1 / 2 pages

← PreviousNext →